BRIEF-Azurrx Biopharma, Mayoly Spindler announce IMPD submission By: Reuters: Company News October 20, 2017 at 08:51 AM EDT * Azurrx Biopharma and Mayoly Spindler announce MS1819-SD investigational medicinal product dossier (IMPD) submission Read More >> Related Stocks: Azurrx Biopharma Inc